Polymerase Chain Reaction (PCR) Market - Snapshot
The global PCR market is expected to reach a market value of about US$ 7.0 Bn by the end of 2026, expanding at a high single digit CAGR during the forecast period. Rise in R&D expenditure, developments in pharmacogenomics, increase in trend of self-diagnosis of diseases as a preventive means, and emergence of digital PCR technology highly benefiting cancer diagnosis are some factors that are expected to boost the global PCR market during the forecast period. Moreover, increasing research and development activities in advanced molecular biology, genetic engineering, and forensic science are expected to propel the global PCR market during the forecast period. However, the emergence of alternative technology such as next-generation sequencing and the high cost of some commercial PCR technologies are expected to hamper the PCR market.
The global PCR market can be segmented based on product and end-user. In terms of product, the global market can be classified into instruments, reagents, and consumables. The reagents segment dominates the global PCR market, in terms of value, owing to its high consumption. This segment is also expected to expand at a significant CAGR owing to increasing innovation in reagents specificity, rising prevalence of infectious diseases, increasing geriatric population, and availability of different types of tests that require multiple types of reagents. The instruments segment can be further sub-segmented into standard PCR systems, RT PCR systems, and digital PCR systems. Among them, the RT PCR sub-segment is expected to hold a major market share of the instrument segment of the global PCR market by the end of 2026, while the digital PCR systems sub-segment is projected to expand at a prominent CAGR during the forecast period.
In terms of end-user, the global PCR market can be segregated into pharmaceutical and biotechnology industries, clinical diagnostics labs and hospitals, academic and research organizations, and others. The pharmaceutical and biotechnology industry segment held a major share of the market in 2017. Continuous development in pharmaceutical and biotechnology industries has driven the evolution of PCR techniques. The advent of these techniques has enabled scientists to identify novel genes, genetic variation, and gene expression in the tissues of an organism, which in turn has led to the comparative analysis of normal and diseased tissues. The clinical diagnostics labs and hospitals segment is projected to expand at a significant CAGR during the forecast period owing to the increase in applications of the PCR technique for the diagnosis of infectious diseases and cancer. For instance, Centers for Disease Control and Prevention (CDC) published a report, in 2012, on polymerase chain reaction (PCR) for timely diagnosis of the disease. The report stated that PCR is an important tool for the diagnosis of pertussis. Moreover, PCR, when combined with mass spectrometry, helps identify clinically important pathogens such as Bordetella pertussis, influenza A virus, and Neisseria meningitides.
In terms of geography, the global PCR market has been segmented into North America, Europe, Asia Pacific, and Rest of the World. North America dominates the global PCR market. Rising incidence of various types of cancer and metabolic diseases that demand advanced diagnosis and therapies are major factors driving the market in North America. Moreover, the advent of automated PCR instruments and higher purchasing power and affordability are fueling the growth of the global PCR market in developed countries such as the U.K., France, Italy, and Germany coupled with less stringent regulatory approval processes as compared to the U.S. are major factors boosting the PCR market in Europe. The market in Asia Pacific is projected to expand at a significantly high CAGR during the forecast period owing to improving health care infrastructure, and rising private and public investment in life science research and technological advancements in countries such as China and India.
Major players operating in the global PCR market include Bio-Rad Laboratories, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc. Becton, Dickinson and Company, Abbott, Siemens Healthcare GmbH (Siemens AG), bioMérieux SA, Danaher Corporation, and Agilent Technologies. Key players are expanding their product portfolio through mergers & acquisitions and partnerships & collaborations with leading pharmaceutical and biotechnology companies and by offering technologically advanced products.
Polymerase Chain Reaction (PCR) Market - Overview
This comprehensive report by Transparency Market Research analyzes the global PCR market for the period between 2018 and 2026. An in-depth and unbiased market assessment has been made, which offers readers an in-depth and accurate analysis. Market projections have been offered in terms of value (US$ Mn). Stakeholders of this report include companies and intermediaries engaged in research & development of diagnostic reagents, instruments, and consumables; PCR service providers, research and development laboratories, clinical diagnostic laboratories, and academic and research institutes involved in the clinical diagnosis and research activities related to PCR technology.
The global PCR market has been studied for the forecast period from 2018 to 2026. For research, 2017 has been considered as the base year and 2016 as the historical year. The global PCR market report comprises an elaborate executive summary that provides overall information about various segments of the market. The report provides a detailed competitive landscape, by major players operating in this market along with their shares (value %) of the global PCR market for 2017. The report also provides detail company profiles of emerging market players operating in the global PCR market.
The market overview section comprises impact factors such as key market dynamics including drivers, restraints, and opportunities, affecting the global PCR market. These factors are likely to aid stakeholders establish a strong foothold in the global PCR market. Furthermore, the market overview section comprises key industry events, product portfolio overview of leading players and market attractiveness analysis in the global PCR market. The market attractiveness analysis provides a graphical view comparing the expansion and market dynamics in various segments and countries to identify the most attractive market.
The global PCR market has been segmented based product and end-user. In terms of product, the global PCR market has been segmented into instruments, reagents, and consumables. The instruments segment has been further sub-segmented into standard PCR, RT PCR, and digital PCR. In terms of end-user, the global PCR market has been categorized into pharmaceutical and biotechnology industries, clinical diagnostics labs and hospitals, academic and research organizations, and others.
In terms of geography, the global PCR market has been segmented into North America, Europe, Asia Pacific, and Rest of the World. Moreover, quantitative analysis for major countries comprising the U.S., Canada, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Australia & New Zealand, has also been provided in the report. A detailed qualitative analysis of factors responsible for driving and restraining the PCR market in various regions has been provided in this section.
The report provides a detailed outline/blueprint of the PCR market globally that is expected to assist new companies establish their presence and market players in expanding their share in the market. The report concludes with the company profile section, which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies, and recent developments for market players.
Major players operating in the global PCR market include Bio-Rad Laboratories, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc. Becton, Dickinson and Company, Abbott, Siemens Healthcare GmbH (Siemens AG), bioMérieux SA, Danaher Corporation, and Agilent Technologies.
The global PCR market has been segmented into:
- Global PCR market, by Product
- Standard PCR
- RT PCR
- Digital PCR
- Global PCR market, by End-user
- Pharmaceutical and Biotechnology Industries
- Clinical Diagnostics Labs and Hospitals
- Academic and Research Organizations
- Global PCR market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Rest of the World
- North America